Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Telomeres, aging, and cancer: the big picture

Peter M. Lansdorp

Blood (2022) 139 (6): 813–821.

https://doi.org/10.1182/blood.2021014299

Published: 2022

Journal Articles

Prolonged self-renewal activity unmasks telomerase control of telomere homeostasis and function of mouse hematopoietic stem cells

Sanja Sekulovic, Vala Gylfadottir, Irma Vulto, Maura Gasparetto, Yasmine Even, Christy Brookes, Clayton Smith, Connie J. Eaves, Peter M. Lansdorp, Fabio M. Rossi, R. Keith Humphries

Blood (2011) 118 (7): 1766–1773.

https://doi.org/10.1182/blood-2010-11-319632

Published: 2011

Includes: Supplemental data

Journal Articles

TINF2 Mutations In Patients with Aplastic Anemia Result In Low TIN2 Expression In Hematopoietic Cells and Very Short Telomeres.

Rodrigo Calado, MD, PhD, Sharon A Savage, MD, Nathan R Peterson, B.A., Tomoiku Takaku, Peter M. Lansdorp, MD, PhD, Irina Maric, Neal S. Young, MD

Blood (2010) 116 (21): 1165.

https://doi.org/10.1182/blood.V116.21.1165.1165

Published: 2010

Journal Articles

Longitudinal Changes In Telomere Length In Patients with Dyskeratosis Congenita

Blanche P Alter, Neelam Giri, MD, Peter M. Lansdorp, MD, PhD, Gabriela M. Baerlocher, MD, Philip S Rosenberg, PhD, Sharon Savage, MD

Blood (2010) 116 (21): 2230.

https://doi.org/10.1182/blood.V116.21.2230.2230

Published: 2010

Journal Articles

Telomere Dysfunction in Bone Marrow Failure.

Peter M. Lansdorp, MD, PhD

Blood (2009) 114 (22): SCI-12.

https://doi.org/10.1182/blood.V114.22.SCI-12.SCI-12

Published: 2009

Journal Articles

Correlation of Telomere Length in Blood, Buccal Cells, and Fibroblasts From Patients with Inherited Bone Marrow Failure Syndromes.

Shahinaz M Gadalla, MD, PhD, Richard Cawthon, MD, PhD, Neelam Giri, MD, Gabriela Baerlocher, MD, Peter M. Lansdorp, MD, PhD, Blanche P. Alter, MD, MPH, Sharon A Savage, MD, FAAP

Blood (2009) 114 (22): 1083.

https://doi.org/10.1182/blood.V114.22.1083.1083

Published: 2009

Journal Articles

Probing the mitotic history and developmental stage of hematopoietic cells using single telomere length analysis (STELA)

Mark Hills, Kai Lücke, Elizabeth A. Chavez, Connie J. Eaves, Peter M. Lansdorp

Blood (2009) 113 (23): 5765–5775.

https://doi.org/10.1182/blood-2009-01-198374

Published: 2009

Includes: Supplemental data

Journal Articles

High Prevalence of TERT Mutations in Chronic Lymphocytic Leukemia

Mark Hills, Alexander Roeth, MD, Holger Nückel, MD, Doug Horsman, Jan Duerig, Randy D. Gascoyne, MD, Peter M. Lansdorp, MD, PhD

Blood (2008) 112 (11): 3126.

https://doi.org/10.1182/blood.V112.11.3126.3126

Published: 2008

Journal Articles

Very Short Telomeres Are Characteristic of Dyskeratosis Congenita and Not Other Inherited Bone Marrow Failure Syndromes

Blanche P. Alter, MD, MPH, Gabriela Baerlocher, MD, Neelam Giri, MD, Peter M. Lansdorp, MD, PhD, Sharon A Savage, MD, FAAP

Blood (2008) 112 (11): 1044.

https://doi.org/10.1182/blood.V112.11.1044.1044

Published: 2008

Journal Articles

TERT Mutations in Patients with Squamous Cell Carcinoma of the Tongue and Refractory Anemia

Geraldine Aubert, PhD, Mark Hills, PhD, Carol Cremin, MSc, CCGC, Irma Vulto, Barbara McGillivray, MD, FRCPC, FCCMG, Peter M. Lansdorp, MD, PhD

Blood (2008) 112 (11): 3096.

https://doi.org/10.1182/blood.V112.11.3096.3096

Published: 2008

Journal Articles

Characterization of Novel Natural Mutations in Telomere Binding Protein Factor (TIN2) Identified in Patients with Bone-Marrow Failure Syndromes

Zhong-Tao Xin, PhD, Rodrigo Calado, MD, PhD, Sharon A Savage, MD, FAAP, Peter M Lansdorp, Neal S Young, MD, Hinh Ly, PhD

Blood (2008) 112 (11): 3101.

https://doi.org/10.1182/blood.V112.11.3101.3101

Published: 2008

Journal Articles

Probing the Mitotic History and Developmental Stage of Hematopoietic Cells Using Single Telomere Length Analysis (STELA)

Mark Hills, Kai Lucke, Connie J. Eaves, PhD, Peter M. Lansdorp, MD, PhD

Blood (2008) 112 (11): 2449.

https://doi.org/10.1182/blood.V112.11.2449.2449

Published: 2008

Journal Articles

Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita

Frederick D. Goldman, Geraldine Aubert, Al J. Klingelhutz, Mark Hills, Sarah R. Cooper, Wendy S. Hamilton, Annette J. Schlueter, Karen Lambie, Connie J. Eaves, Peter M. Lansdorp

Blood (2008) 111 (9): 4523–4531.

https://doi.org/10.1182/blood-2007-10-120204

Published: 2008

Journal Articles

Telomeres, stem cells, and hematology

Peter M. Lansdorp

Blood (2008) 111 (4): 1759–1766.

https://doi.org/10.1182/blood-2007-09-084913

Published: 2008

Journal Articles

The Impact of Telomere Shortening in Dyskeratosis Congenita Cells on DNA Damage Response Pathways.

Travis Witt, BS, Aloysius Klingelhutz, PhD, Erik Westin, BS, Preeti Satyanarayana, MD, Peter M. Lansdorp, MD, PhD, Frederick D. Goldman, MD

Blood (2007) 110 (11): 4052.

https://doi.org/10.1182/blood.V110.11.4052.4052

Published: 2007

Journal Articles

Constitutional Loss-of-Function Mutations in Telomerase Are Genetic Risk Factors for Acute Myeloid Leukemia.

Rodrigo T. Calado, MD, PhD, Joshua A. Regal, BS, William T. Yewdell, BS, Roberto P. Falcao, MD, PhD, Leandro Figueiredo, MD, Elihu H. Estey, MD, Marco A. Zago, MD, PhD, Mark Hills, PhD, Stephen J. Chanock, MD, Peter M. Lansdorp, MD, PhD, Neal S. Young, MD

Blood (2007) 110 (11): 16.

https://doi.org/10.1182/blood.V110.11.16.16

Published: 2007

Journal Articles

Loss of Primitive Hematopoietic Cells in Patients with Dyskeratosis Congenita.

Geraldine Aubert, Frederick D. Goldman, Al J. Klingelhutz, Mark Hills, Sara R. Cooper, Wendy S. Hamilton, Annette Schlueter, Connie J. Eaves, Peter M. Lansdorp

Blood (2007) 110 (11): LB3.

https://doi.org/10.1182/blood.V110.11.LB3.lb3

Published: 2007

Journal Articles

TINF2 , a Component of the Shelterin Telomere Protection Complex, Is Mutated in Dyskeratosis Congenita.

Sharon A. Savage, MD, Neelam Giri, MD, Gabriela M. Baerlocher, MD, Nick Orr, PhD, Peter M. Lansdorp, MD, PhD, Blanche P. Alter, MD

Blood (2007) 110 (11): 835.

https://doi.org/10.1182/blood.V110.11.835.835

Published: 2007

Journal Articles

Hematopoietic stem-cell behavior in nonhuman primates

Bryan E. Shepherd, Hans-Peter Kiem, Peter M. Lansdorp, Cynthia E. Dunbar, Geraldine Aubert, Andre LaRochelle, Ruth Seggewiss, Peter Guttorp, Janis L. Abkowitz

Blood (2007) 110 (6): 1806–1813.

https://doi.org/10.1182/blood-2007-02-075382

Published: 2007

Journal Articles

Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita

Blanche P. Alter, Gabriela M. Baerlocher, Sharon A. Savage, Stephen J. Chanock, Babette B. Weksler, Judith P. Willner, June A. Peters, Neelam Giri, Peter M. Lansdorp

Blood (2007) 110 (5): 1439–1447.

https://doi.org/10.1182/blood-2007-02-075598

Published: 2007

Includes: Supplemental data

NARROW

Telomeres, aging, and cancer: the big picture

Prolonged self-renewal activity unmasks telomerase control of telomere homeostasis and function of mouse hematopoietic stem cells

TINF2 Mutations In Patients with Aplastic Anemia Result In Low TIN2 Expression In Hematopoietic Cells and Very Short Telomeres.

Longitudinal Changes In Telomere Length In Patients with Dyskeratosis Congenita

Telomere Dysfunction in Bone Marrow Failure.

Correlation of Telomere Length in Blood, Buccal Cells, and Fibroblasts From Patients with Inherited Bone Marrow Failure Syndromes.

Probing the mitotic history and developmental stage of hematopoietic cells using single telomere length analysis (STELA)

High Prevalence of TERT Mutations in Chronic Lymphocytic Leukemia

Very Short Telomeres Are Characteristic of Dyskeratosis Congenita and Not Other Inherited Bone Marrow Failure Syndromes

TERT Mutations in Patients with Squamous Cell Carcinoma of the Tongue and Refractory Anemia

Characterization of Novel Natural Mutations in Telomere Binding Protein Factor (TIN2) Identified in Patients with Bone-Marrow Failure Syndromes

Probing the Mitotic History and Developmental Stage of Hematopoietic Cells Using Single Telomere Length Analysis (STELA)

Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita

Telomeres, stem cells, and hematology

The Impact of Telomere Shortening in Dyskeratosis Congenita Cells on DNA Damage Response Pathways.

Constitutional Loss-of-Function Mutations in Telomerase Are Genetic Risk Factors for Acute Myeloid Leukemia.

Loss of Primitive Hematopoietic Cells in Patients with Dyskeratosis Congenita.

TINF2 , a Component of the Shelterin Telomere Protection Complex, Is Mutated in Dyskeratosis Congenita.

Hematopoietic stem-cell behavior in nonhuman primates

Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only